N

Neuca SA
WSE:NEU

Watchlist Manager
Neuca SA
WSE:NEU
Watchlist
Price: 835 PLN 2.58% Market Closed
Market Cap: 3.8B PLN

Profitability Summary

Neuca SA's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
Neuca SA

Revenue
13.3B PLN
Cost of Revenue
-11.8B PLN
Gross Profit
1.5B PLN
Operating Expenses
-1.3B PLN
Operating Income
249.1m PLN
Other Expenses
-95.3m PLN
Net Income
153.8m PLN

Margins Comparison
Neuca SA Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
PL
Neuca SA
WSE:NEU
3.8B PLN
11%
2%
1%
US
Mckesson Corp
NYSE:MCK
102.1B USD
3%
1%
1%
US
Amerisourcebergen Corp
LSE:0HF3
65.8B USD
4%
1%
0%
US
Cencora Inc
NYSE:COR
65.7B USD
4%
1%
0%
US
Cardinal Health Inc
NYSE:CAH
49B USD
4%
1%
1%
AU
Sigma Healthcare Ltd
ASX:SIG
33.8B AUD
24%
12%
9%
CN
Huadong Medicine Co Ltd
SZSE:000963
69.2B CNY
33%
11%
9%
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
66.2B CNY
10%
3%
2%
US
Henry Schein Inc
NASDAQ:HSIC
9.1B USD
31%
6%
3%
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
30%
9%
7%
CN
Sinopharm Group Co Ltd
HKEX:1099
61.6B HKD
7%
3%
1%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
Neuca SA Competitors

Country Company Market Cap ROE ROA ROCE ROIC
PL
Neuca SA
WSE:NEU
3.8B PLN
15%
3%
16%
9%
US
Mckesson Corp
NYSE:MCK
102.1B USD
-170%
5%
35%
24%
US
Amerisourcebergen Corp
LSE:0HF3
65.8B USD
144%
2%
24%
17%
US
Cencora Inc
NYSE:COR
65.7B USD
144%
2%
24%
17%
US
Cardinal Health Inc
NYSE:CAH
49B USD
-52%
3%
23%
17%
AU
Sigma Healthcare Ltd
ASX:SIG
33.8B AUD
19%
11%
19%
14%
CN
Huadong Medicine Co Ltd
SZSE:000963
69.2B CNY
16%
10%
19%
14%
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
66.2B CNY
8%
2%
8%
4%
US
Henry Schein Inc
NASDAQ:HSIC
9.1B USD
11%
4%
10%
6%
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
7%
3%
9%
5%
CN
Sinopharm Group Co Ltd
HKEX:1099
61.6B HKD
9%
2%
12%
5%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less